Loading...
UK Trademark — IPO
OncoCollapse
Application UK00801546641 · DO-NOT-DISPLAY
Quick Facts
| Application Number | UK00801546641 |
| Status | DO-NOT-DISPLAY |
| Owner | AELIN THERAPEUTICS |
| Filed | 2020-06-29 |
| Registered | 2021-01-07 |
| Renewal Due | 2030-06-29 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
OncoCollapse has a current status of DO-NOT-DISPLAY.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical products and drugs; pharmaceutical products and drugs based on peptides; peptides as pharmaceutical products and drugs to induce protein aggregation; peptides as pharmaceutical products and drugs to induce protein aggregation resulting in proteostatic collapse.
Class 42 — Scientific & IT Services
Medical and pharmaceutical research services; pharmaceutical research and development of pharmaceutical products and drugs based on peptides; pharmaceutical research and development of pharmaceutical products and drugs based on protein aggregation stimulating peptides; pharmaceutical research and development of pharmaceutical products and drugs based on aggregation stimulating peptides leading to proteostatic collapse.
Timeline
- Filed: 2020-06-29
- Registered: 2021-01-07
- Renewal due: 2030-06-29
About This Trademark
'OncoCollapse' is a do-not-display trademark on the UK IPO register, owned by AELIN THERAPEUTICS. The application (UK00801546641) was filed on 29 June 2020 and registered on 7 January 2021. The registration is set to expire on 29 June 2030.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by De Clercq & Partners.
Frequently Asked Questions
Who owns UK trademark UK00801546641 ('OncoCollapse')?
UK trademark UK00801546641 for the mark 'OncoCollapse' in Class 5, 42 is recorded on the UK IPO register as owned by AELIN THERAPEUTICS. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00801546641 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00801546641 for the mark 'OncoCollapse' as do-not-display.
Which Nice classes is UK trademark UK00801546641 registered under?
UK trademark UK00801546641 for the mark 'OncoCollapse' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical products and drugs; pharmaceutical products and drugs based on peptides; peptides as pharmaceutical products and drugs to induce protein aggregation; peptides as pharmaceutical products and drugs to induce protein aggregation resulting in proteostatic collapse. | Class 42: Medical and pharmac…
When was UK trademark UK00801546641 filed?
UK trademark UK00801546641 for the mark 'OncoCollapse' was filed at the UK IPO on 29 June 2020 and registered on 7 January 2021.
When does UK trademark UK00801546641 need to be renewed?
UK trademark UK00801546641 for the mark 'OncoCollapse' is currently recorded as valid until 29 June 2030, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00801546641?
De Clercq & Partners is listed as the attorney / representative of record for UK trademark UK00801546641 for the mark 'OncoCollapse' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "OncoCollapse" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ONCOCOLLAPSESame applicant | 79292101 | 700 | 2020-06-29 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.